Latest Antimalarial drug Stories
Fake Medications in Use in Public Hospital, Many Other Sites ROCKVILLE, Md., Nov.
The largest ever clinical trial in patients hospitalised with severe malaria has concluded that the drug artesunate should now be the preferred treatment for the disease in both children and adults everywhere in the world.
CHAPEL HILL, N.C., Nov. 3, 2010 /PRNewswire/ -- Cempra Pharmaceuticals today announced abstracts to be presented on its novel fluoroketolide antibiotic, solithromycin (CEM-101), at the American Society of Tropical Medicine and Hygiene 59th Annual Meeting, November 3 to 7 in Atlanta.
International Malaria Research Consortium Combines Technologies and Expertise From Two Continents to Tackle Deadly Disease Therapure Biopharma Inc.(Therapure) today announced taking part in the â€œInternational Malaria Research Consortium for the development of novel classes of antimalarialsâ€ ,(the â€œConsortiumâ€) a bold initiative to develop novel classes of drugs against malaria, a deadly disease in desperate need of new treatments. Toronto, ON (Vocus) October 27, 2010...
Community Health Workers can safely and effectively provide integrated management of pneumonia and malaria to communities by dispensing amoxicillin to children with non-severe pneumonia and artemether-lumefantrine to children with malaria (after using rapid diagnostic tests).
Anti-malarial drugs are being used inappropriately for sick children in Zambia with fevers and difficulty breathing â€“ a problem that can be addressed by arming community health workers with a simple rapid-diagnostic test and a supply of antibiotics.
Malaria remains a serious global health problem, killing more than one million people per year.
A team of scientists from The Scripps Research Institute, the Genomics Institute of the Novartis Research Foundation (GNF), and the U. S. Naval Research Detachment in Peru has completed a study that could improve the efficacy of diagnosis and treatment strategies for drug-resistant malaria.
Novartis announced today that scientists at the Novartis Institute for Tropical Diseases (NITD), in collaboration with researchers from the Genomics Institute of the Novartis Research Foundation (GNF), the Swiss Tropical and Public Health Institute and The Scripps Research Institute have discovered a novel compound that shows promise as a next generation treatment for drug resistant malaria.
- The act of sweetening by admixture of some saccharine substance.